For how we live.
Trained on 1.7 million ECGs paired with clinicians' report text, ECG-CLIP reached the same accuracy as the best comparator with about 90% less training data — a bid at the field's labelling bottleneck.
The first double-blind sham-controlled trial of pulmonary vein isolation found quality of life improved in both arms. Most of the benefit patients feel appears not to come from the ablation.
Guidelines have hedged on anticoagulation for people with one stroke risk factor. SINGLE-AF randomised 1,803 patients in South Korea, and the events it counted were very few in both arms.
Comparing US adults vaccinated just before and just after the changeover from the live to the recombinant shingles vaccine, researchers found a 9% lower cardiovascular burden over seven years.
A sibling-controlled cohort of 1.1 million men, a genetic analysis of 712 traits and a UK Biobank study of fitness change converge — and they agree on where the exception is.
A secondary analysis of the VITAL-AF trial reports a screening benefit only in the top risk decile — with a confidence interval whose lower bound sits at 0.01.
A systematic review of 27 studies finds women reach higher drug concentrations at the same psychotropic dose. A separate review of 103 atrial fibrillation trials finds 43% under-enrolled women against disease prevalence.
The STABLED trial randomized 331 atrial fibrillation patients with a recent stroke to ablation plus anticoagulation or anticoagulation alone. The two groups ended up nearly identical.
In 2,286 patients with sleep apnea undergoing major surgery, a measure of how deeply and how long oxygen fell — not the apnea-hypopnea index — tracked 30-day cardiovascular events and death.